Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000715812-19-000006
Filing Date
2019-03-14
Accepted
2019-03-14 11:50:35
Documents
42
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 bsyn20190131.htm 10-Q 180747
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER bsynx311.htm EX-31.1 9416
9 CERTIFICATION OF CHIEF ACCOUNTING OFFICER bsynx312.htm EX-31.2 8845
10 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED bsynx321.htm EX-32.1 3467
11 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED bsynx322.htm EX-32.2 3744
  Complete submission text file 0000715812-19-000006.txt   1233305

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE bsyn-20170131.xml EX-101.INS 156529
3 XBRL SCHEMA FILE bsyn-20170131.xsd EX-101.SCH 15833
4 XBRL CALCULATION FILE bsyn-20170131_cal.xml EX-101.CAL 38861
5 XBRL DEFINITION FILE bsyn-20170131_def.xml EX-101.DEF 20142
6 XBRL LABEL FILE bsyn-20170131_lab.xml EX-101.LAB 116117
7 XBRL PRESENTATION FILE bsyn-20170131_pre.xml EX-101.PRE 87793
Mailing Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603
Business Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603 8479560471
BIOSYNERGY INC (Filer) CIK: 0000715812 (see all company filings)

EIN.: 362880990 | State of Incorp.: IL | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-12459 | Film No.: 19680288
SIC: 3829 Measuring & Controlling Devices, NEC